Janssen Files Additional Indication For OneDuro Patch In Chronic Pain
This article was originally published in PharmAsia News
Executive Summary
Janssen Pharmaceuticals has applied for an additional indication of OneDuro Patch (fentanyl), a drug used for pain during cancer treatment, for the treatment of “moderate to severe chronic pain,” the company announced Dec. 21.